US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Intensity Therapeutics, Inc.

5.85

-0.6700-10.28%

Volume:85.14K

Turnover:506.64K

Market Cap:351.38M

PE:-0.46

High:6.29

Open:6.16

Low:5.60

Close:6.52

52wk High:62.49

52wk Low:4.63

Shares:60.07M

Float Shares:54.78M

Volume Ratio:0.61

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-12.7855

EPS(LYR):-29.2443

ROE:-234.70%

ROA:-101.66%

PB:48.65

PE(LYR):-0.20

Loading ...

Overview Company News Filings

Intensity Therapeutics Inc trading halted, news pending

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

BRIEF-Intensity Therapeutics Announces Reverse Stock Split

Intensity Therapeutics Implements 1-for-25 Reverse Stock Split

BRIEF-Intensity Therapeutics Highlights 2025 Milestones And Outlines 2026 Strategic Priorities

Intensity Therapeutics Inc. Outlines 2026 Strategy: Pursuing Additional Peer-Reviewed Publications, Advancing Regulatory Engagement, Opportunistically Raising Capital, and Planning Phase 3 Breast Cancer Study Initiation

Intensity Therapeutics Inc - Plans to File Protocol Amendment for Invincible-4 Study and Reinitiate Enrollment in Q1 2026

THOMSON REUTERS

Intensity Therapeutics Inc: to Raise Additional Capital During 2026 to Reinitiate Patient Enrollment and Site Activations in Invicible-3 Study

THOMSON REUTERS

Intensity Therapeutics Inc. Releases Clinical Data on Anthracycline-Free Treatment for Early-Stage Triple Negative Breast Cancer

Intensity Therapeutics Reports Favorable Early Results from Phase 2 Triple Negative Breast Cancer Trial

BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companies

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Ulta Beauty, Victoria's Secret

BUZZ-Intensity Therapeutics jumps after Nasdaq grants compliance extension

BRIEF-Intensity Therapeutics Granted 180-Day Extension

Intensity Therapeutics Granted 180-Day Extension to Regain Compliance With Nasdaq's Minimum Bid Price Requirement

THOMSON REUTERS

BRIEF-Intensity Therapeutics Files For Offering Of Up To $30 Million Common Stock - SEC Filing

Intensity Therapeutics Unveils New Breast Cancer Therapy Data at 2025 SABCS

Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium

THOMSON REUTERS

Intensity Therapeutics Inc - Files for Offering of up to $30 Mln Common Stock - SEC Filing

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Curis (CRIS) and Intensity Therapeutics, Inc. (INTS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INTS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTS\",,,,,undefined,":{"symbol":"INTS","market":"US","secType":"STK","nameCN":"Intensity Therapeutics, Inc.","latestPrice":5.85,"timestamp":1771617164113,"preClose":6.52,"halted":0,"volume":85138,"delay":0,"changeRate":-0.10276073619631901,"floatShares":54782900,"shares":60065000,"eps":-12.785525,"marketStatus":"Trading","change":-0.67,"latestTime":"02-20 14:53:38 EST","open":6.16,"high":6.29,"low":5.6,"amount":506643.89298999996,"amplitude":0.105828,"askPrice":5.93,"askSize":100,"bidPrice":5.76,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-12.785525,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771621200000},"marketStatusCode":2,"adr":0,"listingDate":1666324800000,"exchange":"NASDAQ","adjPreClose":6.52,"preHourTrading":{"tag":"盘前","latestPrice":6.28,"preClose":6.52,"latestTime":"09:29 EST","volume":1355,"amount":8410.8206335,"timestamp":1771597799117,"change":-0.24,"changeRate":-0.03681,"amplitude":0.046426},"postHourTrading":{"tag":"盘后","latestPrice":6.7,"preClose":6.52,"latestTime":"19:48 EST","volume":2369,"amount":15576.135,"timestamp":1771548531851,"change":0.18,"changeRate":0.027607,"amplitude":0.021472},"volumeRatio":0.609597},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTS\",,,,,undefined,":{"symbol":"INTS","floatShares":54782900,"roa":"-101.66%","roe":"-234.70%","lyrEps":-29.2443,"volumeRatio":0.609597,"shares":60065000,"dividePrice":0,"high":6.29,"amplitude":0.105828,"preClose":6.52,"low":5.6,"week52Low":4.6325,"pbRate":"48.65","week52High":62.49,"institutionHeld":0,"latestPrice":5.85,"eps":-12.785525,"divideRate":0,"volume":85138,"delay":0,"ttmEps":-12.785525,"open":6.16,"prevYearClose":10.255,"prevWeekClose":6.255,"prevMonthClose":9.14,"prevQuarterClose":10.255,"fiveDayClose":9.2775,"twentyDayClose":10.1075,"sixtyDayClose":10.2075},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"INTS","defaultRemindTime":1771511400000,"type":"split","dateTimestamp":1771477200000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8333,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1763010000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INTS","date":"2026-02-18","current":-0.509952,"percent":0.795597,"low":-15.25821,"twenty":-6.41284,"median":-2.923378,"eighty":-1.171051,"high":-0.31723,"avg":-4.027215,"sd":3.271854,"marketCap":14151625},"quantilePoints":[{"date":"2022-10-20","current":-9.173693,"twenty":-9.173693,"median":-9.173693,"eighty":-9.173693,"marketCap":80934718},{"date":"2023-07-07","current":-12.000673,"twenty":-12.000673,"median":-11.893737,"eighty":-9.173693,"marketCap":78596262},{"date":"2023-07-14","current":-11.805305,"twenty":-12.014248,"median":-11.893737,"eighty":-11.600651,"marketCap":77316730},{"date":"2023-07-21","current":-12.682867,"twenty":-12.306769,"median":-11.947205,"eighty":-11.660654,"marketCap":83064168},{"date":"2023-07-28","current":-11.867988,"twenty":-12.682867,"median":-12.014248,"eighty":-11.805305,"marketCap":77727261},{"date":"2023-08-04","current":-12.81868,"twenty":-12.682867,"median":-12.066484,"eighty":-11.867988,"marketCap":83953652},{"date":"2023-08-11","current":-12.933599,"twenty":-12.933599,"median":-12.306769,"eighty":-11.888882,"marketCap":84706293},{"date":"2023-08-18","current":-9.652146,"twenty":-12.81868,"median":-12.1197,"eighty":-11.660654,"marketCap":80327292},{"date":"2023-08-25","current":-9.800135,"twenty":-12.808233,"median":-12.000673,"eighty":-9.800135,"marketCap":81558886},{"date":"2023-09-01","current":-9.487714,"twenty":-12.770623,"median":-11.912204,"eighty":-9.783692,"marketCap":78958855},{"date":"2023-09-08","current":-9.093078,"twenty":-12.755579,"median":-11.893737,"eighty":-9.638992,"marketCap":75674604},{"date":"2023-09-15","current":-8.073601,"twenty":-12.70794,"median":-11.836647,"eighty":-9.487714,"marketCap":67190291},{"date":"2023-09-22","current":-6.034647,"twenty":-12.632721,"median":-11.600651,"eighty":-9.000996,"marketCap":50221663},{"date":"2023-09-29","current":-6.626601,"twenty":-12.586753,"median":-9.923459,"eighty":-8.293939,"marketCap":55148039},{"date":"2023-10-06","current":-7.251442,"twenty":-12.570873,"median":-9.800135,"eighty":-7.560574,"marketCap":60348102},{"date":"2023-10-13","current":-6.626601,"twenty":-12.448015,"median":-9.783692,"eighty":-7.192246,"marketCap":55148039},{"date":"2023-10-20","current":-4.636976,"twenty":-12.331842,"median":-9.61926,"eighty":-6.745518,"marketCap":38589943},{"date":"2023-10-23","current":-4.96584,"twenty":-12.319306,"median":-9.578152,"eighty":-6.686849,"marketCap":41326818},{"date":"2023-11-03","current":-4.932954,"twenty":-12.157898,"median":-9.487714,"eighty":-6.567406,"marketCap":41053131},{"date":"2023-11-10","current":-4.609845,"twenty":-12.119112,"median":-9.173693,"eighty":-6.48519,"marketCap":38364150},{"date":"2023-11-17","current":-3.237228,"twenty":-12.035142,"median":-8.862874,"eighty":-6.287872,"marketCap":28737191},{"date":"2023-11-24","current":-3.590621,"twenty":-12.006103,"median":-8.517567,"eighty":-5.189368,"marketCap":31874301},{"date":"2023-12-01","current":-3.784438,"twenty":-11.971208,"median":-8.209257,"eighty":-5.01517,"marketCap":33594828},{"date":"2023-12-08","current":-6.177413,"twenty":-11.939029,"median":-7.613192,"eighty":-5.01517,"marketCap":54837508},{"date":"2023-12-15","current":-12.447487,"twenty":-12.056037,"median":-8.209257,"eighty":-5.034902,"marketCap":110497578},{"date":"2023-12-22","current":-9.544103,"twenty":-12.056037,"median":-8.517567,"eighty":-5.074891,"marketCap":84723949},{"date":"2023-12-29","current":-12.200391,"twenty":-12.097826,"median":-8.854652,"eighty":-5.093498,"marketCap":108304078},{"date":"2024-01-05","current":-12.586479,"twenty":-12.221667,"median":-9.093078,"eighty":-5.095649,"marketCap":111731422},{"date":"2024-01-12","current":-9.080797,"twenty":-12.136622,"median":-9.173576,"eighty":-5.162954,"marketCap":80611136},{"date":"2024-01-19","current":-7.443783,"twenty":-12.119504,"median":-9.086938,"eighty":-5.189368,"marketCap":66079197},{"date":"2024-01-26","current":-6.94959,"twenty":-12.056037,"median":-8.862874,"eighty":-5.265897,"marketCap":61692196},{"date":"2024-02-02","current":-7.706323,"twenty":-12.006103,"median":-8.582973,"eighty":-5.358906,"marketCap":68409791},{"date":"2024-02-09","current":-5.497898,"twenty":-11.971208,"median":-8.279141,"eighty":-5.454656,"marketCap":48805382},{"date":"2024-02-16","current":-4.67939,"twenty":-11.939029,"median":-8.106172,"eighty":-5.189368,"marketCap":41539412},{"date":"2024-02-23","current":-4.63306,"twenty":-11.915897,"median":-7.791263,"eighty":-5.065946,"marketCap":41128131},{"date":"2024-03-01","current":-5.714107,"twenty":-11.893737,"median":-7.613192,"eighty":-5.065946,"marketCap":50724694},{"date":"2024-03-08","current":-8.617491,"twenty":-11.891795,"median":-7.659757,"eighty":-5.094215,"marketCap":76498323},{"date":"2024-03-15","current":-6.42451,"twenty":-11.880524,"median":-7.613192,"eighty":-5.12966,"marketCap":57031008},{"date":"2024-03-22","current":-7.168217,"twenty":-11.842915,"median":-7.462714,"eighty":-5.183371,"marketCap":75538667},{"date":"2024-03-28","current":-6.569781,"twenty":-11.793205,"median":-7.382998,"eighty":-5.190398,"marketCap":69232353},{"date":"2024-04-05","current":-6.062412,"twenty":-11.727976,"median":-7.320234,"eighty":-5.219219,"marketCap":63885696},{"date":"2024-04-12","current":-5.919308,"twenty":-11.648653,"median":-7.270395,"eighty":-5.328019,"marketCap":62377665},{"date":"2024-04-19","current":-4.956607,"twenty":-11.467325,"median":-7.168217,"eighty":-5.219219,"marketCap":52232726},{"date":"2024-04-26","current":-5.106216,"twenty":-10.872247,"median":-7.057617,"eighty":-5.181486,"marketCap":53809304},{"date":"2024-05-03","current":-5.203787,"twenty":-10.575732,"median":-7.004794,"eighty":-5.110119,"marketCap":54837508},{"date":"2024-05-10","current":-4.89156,"twenty":-10.334812,"median":-6.920091,"eighty":-5.07751,"marketCap":51547257},{"date":"2024-05-17","current":-5.064674,"twenty":-10.138832,"median":-6.816961,"eighty":-5.04775,"marketCap":69917822},{"date":"2024-05-24","current":-5.034882,"twenty":-10.040205,"median":-6.769756,"eighty":-5.01517,"marketCap":69506541},{"date":"2024-05-31","current":-4.905782,"twenty":-10.013896,"median":-6.720408,"eighty":-4.982612,"marketCap":67724322},{"date":"2024-06-07","current":-4.945811,"twenty":-9.945635,"median":-6.626601,"eighty":-4.965367,"marketCap":68276920},{"date":"2024-06-14","current":-4.747756,"twenty":-9.859151,"median":-6.577272,"eighty":-4.943699,"marketCap":65542772},{"date":"2024-06-21","current":-4.638498,"twenty":-9.834825,"median":-6.527942,"eighty":-4.905297,"marketCap":64034465},{"date":"2024-06-28","current":-4.887408,"twenty":-9.833021,"median":-6.527942,"eighty":-4.896744,"marketCap":67470661},{"date":"2024-07-05","current":-4.817184,"twenty":-9.806712,"median":-6.504734,"eighty":-4.887289,"marketCap":66501232},{"date":"2024-07-12","current":-4.986137,"twenty":-9.800135,"median":-6.468725,"eighty":-4.878216,"marketCap":68833622},{"date":"2024-07-15","current":-5.055665,"twenty":-9.800135,"median":-6.445726,"eighty":-4.87855,"marketCap":69793453},{"date":"2024-08-02","current":-4.807351,"twenty":-9.796846,"median":-6.435118,"eighty":-4.877213,"marketCap":66365484},{"date":"2024-08-09","current":-4.588835,"twenty":-9.783692,"median":-6.41284,"eighty":-4.86516,"marketCap":63348871},{"date":"2024-08-16","current":-3.955696,"twenty":-9.783692,"median":-6.339457,"eighty":-4.820512,"marketCap":59632119},{"date":"2024-08-23","current":-3.896315,"twenty":-9.757383,"median":-6.270563,"eighty":-4.807351,"marketCap":58736948},{"date":"2024-08-30","current":-3.86434,"twenty":-9.645569,"median":-6.204474,"eighty":-4.781352,"marketCap":58254933},{"date":"2024-09-06","current":-3.910018,"twenty":-9.61926,"median":-6.112191,"eighty":-4.747756,"marketCap":58943526},{"date":"2024-09-13","current":-3.837391,"twenty":-9.544103,"median":-6.034647,"eighty":-4.707926,"marketCap":57848664},{"date":"2024-09-20","current":-3.727307,"twenty":-9.537044,"median":-5.97785,"eighty":-4.668296,"marketCap":56189156},{"date":"2024-09-27","current":-3.316207,"twenty":-9.52866,"median":-5.925812,"eighty":-4.63306,"marketCap":49991822},{"date":"2024-10-04","current":-3.2888,"twenty":-9.487714,"median":-5.784184,"eighty":-4.588835,"marketCap":49578667},{"date":"2024-10-11","current":-3.037299,"twenty":-9.487714,"median":-5.559672,"eighty":-4.472545,"marketCap":45787276},{"date":"2024-10-18","current":-2.923378,"twenty":-9.487714,"median":-5.461423,"eighty":-4.216084,"marketCap":44069926},{"date":"2024-10-25","current":-2.923378,"twenty":-9.26612,"median":-5.333882,"eighty":-3.973967,"marketCap":44069926},{"date":"2024-10-31","current":-2.786345,"twenty":-9.192178,"median":-5.307863,"eighty":-3.960154,"marketCap":42004148},{"date":"2024-11-08","current":-2.941649,"twenty":-9.173693,"median":-5.199834,"eighty":-3.926462,"marketCap":44345363},{"date":"2024-11-15","current":-2.689442,"twenty":-9.173505,"median":-5.189027,"eighty":-3.893574,"marketCap":43725630},{"date":"2024-11-22","current":-2.507825,"twenty":-9.109154,"median":-5.115973,"eighty":-3.863938,"marketCap":40772862},{"date":"2024-11-29","current":-2.717615,"twenty":-9.085709,"median":-5.101291,"eighty":-3.84881,"marketCap":44185701},{"date":"2024-12-06","current":-2.321954,"twenty":-9.052999,"median":-5.073692,"eighty":-3.799491,"marketCap":37752650},{"date":"2024-12-13","current":-1.917562,"twenty":-8.931511,"median":-5.06017,"eighty":-3.723653,"marketCap":31177648},{"date":"2024-12-20","current":-1.857563,"twenty":-8.853008,"median":-5.047673,"eighty":-3.619065,"marketCap":30202120},{"date":"2024-12-27","current":-1.764685,"twenty":-8.767209,"median":-5.021654,"eighty":-3.573099,"marketCap":28692014},{"date":"2025-01-03","current":-1.625368,"twenty":-8.642201,"median":-5.01517,"eighty":-3.513045,"marketCap":26426855},{"date":"2025-01-10","current":-1.838802,"twenty":-8.617491,"median":-5.008645,"eighty":-3.463472,"marketCap":29897078},{"date":"2025-01-17","current":-2.572725,"twenty":-8.517567,"median":-4.984374,"eighty":-3.373331,"marketCap":41829936},{"date":"2025-01-24","current":-2.370715,"twenty":-8.346557,"median":-4.965604,"eighty":-3.310726,"marketCap":38545455},{"date":"2025-01-31","current":-2.053117,"twenty":-8.284074,"median":-4.956607,"eighty":-3.212827,"marketCap":33381630},{"date":"2025-02-07","current":-2.238919,"twenty":-8.253306,"median":-4.940989,"eighty":-3.06772,"marketCap":36402592},{"date":"2025-02-14","current":-2.015957,"twenty":-8.160869,"median":-4.905782,"eighty":-3.026792,"marketCap":32777437},{"date":"2025-02-21","current":-2.043827,"twenty":-8.138995,"median":-4.896744,"eighty":-3.006493,"marketCap":33230582},{"date":"2025-02-28","current":-2.099568,"twenty":-8.099657,"median":-4.889484,"eighty":-2.934341,"marketCap":34136870},{"date":"2025-03-07","current":-2.146018,"twenty":-8.038556,"median":-4.87855,"eighty":-2.919724,"marketCap":34892111},{"date":"2025-03-14","current":-2.159953,"twenty":-8.005927,"median":-4.871913,"eighty":-2.813752,"marketCap":35118683},{"date":"2025-03-21","current":-1.801034,"twenty":-7.907089,"median":-4.866947,"eighty":-2.682321,"marketCap":29299223},{"date":"2025-03-28","current":-1.800101,"twenty":-7.780452,"median":-4.846639,"eighty":-2.622879,"marketCap":29284042},{"date":"2025-04-04","current":-1.82903,"twenty":-7.718678,"median":-4.817184,"eighty":-2.548971,"marketCap":29754652},{"date":"2025-04-11","current":-1.810366,"twenty":-7.669259,"median":-4.807351,"eighty":-2.494707,"marketCap":29451033},{"date":"2025-04-17","current":-1.735712,"twenty":-7.632006,"median":-4.806913,"eighty":-2.414832,"marketCap":28236557},{"date":"2025-04-25","current":-0.839954,"twenty":-7.607202,"median":-4.796544,"eighty":-2.376882,"marketCap":13664368},{"date":"2025-05-02","current":-0.521647,"twenty":-7.551589,"median":-4.752722,"eighty":-2.245719,"marketCap":8486148},{"date":"2025-05-09","current":-0.530045,"twenty":-7.466501,"median":-4.747756,"eighty":-2.177388,"marketCap":8622776},{"date":"2025-05-16","current":-0.505526,"twenty":-7.426042,"median":-4.707976,"eighty":-2.157166,"marketCap":7588954},{"date":"2025-05-23","current":-0.365063,"twenty":-7.386285,"median":-4.686306,"eighty":-2.149257,"marketCap":5480321},{"date":"2025-05-30","current":-0.393378,"twenty":-7.360388,"median":-4.668296,"eighty":-2.119771,"marketCap":5905387},{"date":"2025-06-06","current":-0.549666,"twenty":-7.332589,"median":-4.637737,"eighty":-2.099568,"marketCap":8251593},{"date":"2025-06-13","current":-0.392181,"twenty":-7.316341,"median":-4.63306,"eighty":-2.056833,"marketCap":5887424},{"date":"2025-06-20","current":-0.532797,"twenty":-7.300771,"median":-4.609845,"eighty":-2.053117,"marketCap":7998351},{"date":"2025-06-27","current":-0.511084,"twenty":-7.289347,"median":-4.571286,"eighty":-2.034537,"marketCap":7672399},{"date":"2025-07-03","current":-0.492879,"twenty":-7.259023,"median":-4.506472,"eighty":-1.991406,"marketCap":7399101},{"date":"2025-07-11","current":-0.528288,"twenty":-7.195283,"median":-4.389384,"eighty":-1.94521,"marketCap":7930653},{"date":"2025-07-18","current":-0.557015,"twenty":-7.170822,"median":-4.18175,"eighty":-1.91115,"marketCap":8361912},{"date":"2025-07-25","current":-0.542818,"twenty":-7.116406,"median":-4.001374,"eighty":-1.881987,"marketCap":8148790},{"date":"2025-08-01","current":-0.462648,"twenty":-7.091556,"median":-3.972293,"eighty":-1.853811,"marketCap":6945276},{"date":"2025-08-08","current":-0.502341,"twenty":-7.039039,"median":-3.955696,"eighty":-1.829566,"marketCap":6318446},{"date":"2025-08-15","current":-1.11677,"twenty":-7.015013,"median":-3.928289,"eighty":-1.810366,"marketCap":14046731},{"date":"2025-08-22","current":-1.175134,"twenty":-7.006256,"median":-3.910018,"eighty":-1.798683,"marketCap":14780832},{"date":"2025-08-29","current":-1.08871,"twenty":-6.960631,"median":-3.889463,"eighty":-1.782371,"marketCap":13693798},{"date":"2025-09-05","current":-1.066138,"twenty":-6.940264,"median":-3.868908,"eighty":-1.769697,"marketCap":13409881},{"date":"2025-09-12","current":-0.906383,"twenty":-6.917299,"median":-3.862331,"eighty":-1.745683,"marketCap":11400489},{"date":"2025-09-19","current":-0.936024,"twenty":-6.885877,"median":-3.848353,"eighty":-1.727072,"marketCap":11773310},{"date":"2025-09-26","current":-0.967225,"twenty":-6.839125,"median":-3.809527,"eighty":-1.460474,"marketCap":12165754},{"date":"2025-10-03","current":-1.053027,"twenty":-6.813143,"median":-3.783279,"eighty":-1.137571,"marketCap":13244974},{"date":"2025-10-10","current":-1.237502,"twenty":-6.788993,"median":-3.727307,"eighty":-1.12949,"marketCap":15565298},{"date":"2025-10-17","current":-1.024946,"twenty":-6.76879,"median":-3.686198,"eighty":-1.120137,"marketCap":12891775},{"date":"2025-10-24","current":-0.939534,"twenty":-6.749312,"median":-3.590621,"eighty":-1.104352,"marketCap":11817460},{"date":"2025-10-31","current":-5.148132,"twenty":-6.716708,"median":-3.589534,"eighty":-1.099571,"marketCap":64753209},{"date":"2025-11-07","current":-1.892719,"twenty":-6.656725,"median":-3.544596,"eighty":-1.101463,"marketCap":23806615},{"date":"2025-11-14","current":-2.446921,"twenty":-6.626601,"median":-3.5023,"eighty":-1.103492,"marketCap":28717059},{"date":"2025-11-21","current":-1.944844,"twenty":-6.606869,"median":-3.463472,"eighty":-1.104352,"marketCap":22824686},{"date":"2025-11-28","current":-2.043621,"twenty":-6.587138,"median":-3.425742,"eighty":-1.107316,"marketCap":23983940},{"date":"2025-12-05","current":-2.35582,"twenty":-6.574276,"median":-3.358472,"eighty":-1.113245,"marketCap":27647903},{"date":"2025-12-12","current":-3.019626,"twenty":-6.553045,"median":-3.316207,"eighty":-1.116199,"marketCap":35438329},{"date":"2025-12-19","current":-2.137793,"twenty":-6.527942,"median":-3.243133,"eighty":-1.119015,"marketCap":25089135},{"date":"2025-12-26","current":-2.080983,"twenty":-6.524653,"median":-3.176227,"eighty":-1.123804,"marketCap":24422414},{"date":"2026-01-02","current":-2.099408,"twenty":-6.511499,"median":-3.101522,"eighty":-1.12949,"marketCap":24638648},{"date":"2026-01-09","current":-2.221728,"twenty":-6.504734,"median":-3.060412,"eighty":-1.12949,"marketCap":26074201},{"date":"2026-01-16","current":-2.13984,"twenty":-6.495056,"median":-3.033553,"eighty":-1.130611,"marketCap":25113161},{"date":"2026-01-23","current":-2.069211,"twenty":-6.49239,"median":-3.01718,"eighty":-1.136,"marketCap":24284265},{"date":"2026-01-30","current":-1.919766,"twenty":-6.454926,"median":-3.013363,"eighty":-1.137646,"marketCap":22530368},{"date":"2026-02-06","current":-1.733982,"twenty":-6.428753,"median":-2.969787,"eighty":-1.161067,"marketCap":20350010},{"date":"2026-02-13","current":-1.899293,"twenty":-6.415174,"median":-2.923378,"eighty":-1.169405,"marketCap":22290108},{"date":"2026-02-18","current":-1.20583,"twenty":-6.41284,"median":-2.923378,"eighty":-1.171051,"marketCap":14151625}],"updateTime":1771576917539},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INTS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612473567","title":"Intensity Therapeutics Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2612473567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612473567?lang=en_us&edition=fundamental","pubTime":"2026-02-19 08:50","pubTimestamp":1771462217,"startTime":"0","endTime":"0","summary":"19:50 EST Intensity Therapeutics (INTS) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-movi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intensity-therapeutics-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intensity-therapeutics-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","INTS","BK4007","BK4139"],"gpt_icon":0},{"id":"2612738584","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2612738584","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612738584?lang=en_us&edition=fundamental","pubTime":"2026-02-19 08:50","pubTimestamp":1771462200,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nAQN2LMQHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"gpt_icon":0},{"id":"2611163838","title":"BRIEF-Intensity Therapeutics Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2611163838","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611163838?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:25","pubTimestamp":1770992727,"startTime":"0","endTime":"0","summary":"BRIEF-Intensity Therapeutics Announces Reverse Stock SplitFeb 13 (Reuters) - Intensity Therapeutics Inc INTS.O:INTENSITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLITINTENSITY THERAPEUTICS INC - BOARD AP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA6VJGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"gpt_icon":0},{"id":"2611150763","title":"Intensity Therapeutics Implements 1-for-25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2611150763","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611150763?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:59","pubTimestamp":1770991155,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics Inc. has announced a 1-for-25 reverse stock split of its common stock, effective February 18, 2026. The company's shares will begin trading on a split-adjusted basis under the ticker symbol \"INTS\" on February 19, 2026. The move is intended to increase the per share trading price and help the company regain compliance with Nasdaq's minimum bid price requirement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intensity Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on February 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL9z5K7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4585","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","BK4588","SG9999014005.SGD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","INTS","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","BK4139","SG9999014021.USD"],"gpt_icon":0},{"id":"2603681119","title":"BRIEF-Intensity Therapeutics Highlights 2025 Milestones And Outlines 2026 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681119","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603681119?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:54","pubTimestamp":1768308876,"startTime":"0","endTime":"0","summary":"BRIEF-Intensity Therapeutics Highlights 2025 Milestones And Outlines 2026 Strategic PrioritiesJan 13 (Reuters) - Intensity Therapeutics Inc INTS.O:INTENSITY THERAPEUTICS HIGHLIGHTS 2025 MILESTONES AND","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA2RJJTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"gpt_icon":0},{"id":"2603681340","title":"Intensity Therapeutics Inc. Outlines 2026 Strategy: Pursuing Additional Peer-Reviewed Publications, Advancing Regulatory Engagement, Opportunistically Raising Capital, and Planning Phase 3 Breast Cancer Study Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681340","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603681340?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:47","pubTimestamp":1768308434,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics Inc. Outlines 2026 Strategy: Pursuing Additional Peer-Reviewed Publications, Advancing Regulatory Engagement, Opportunistically Raising Capital, and Planning Phase 3 Breast Cancer Study Initiation. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intensity Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on January 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL7Yyky4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2603968158","title":"Intensity Therapeutics Inc - Plans to File Protocol Amendment for Invincible-4 Study and Reinitiate Enrollment in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603968158?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:47","pubTimestamp":1768308420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA2RJJTD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INTS"],"gpt_icon":0},{"id":"2603645681","title":"Intensity Therapeutics Inc: to Raise Additional Capital During 2026 to Reinitiate Patient Enrollment and Site Activations in Invicible-3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2603645681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603645681?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:47","pubTimestamp":1768308420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA2RJJTD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INTS"],"gpt_icon":0},{"id":"2592964947","title":"Intensity Therapeutics Inc. Releases Clinical Data on Anthracycline-Free Treatment for Early-Stage Triple Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2592964947","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592964947?lang=en_us&edition=fundamental","pubTime":"2025-12-18 09:09","pubTimestamp":1766020158,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics Inc. Releases Clinical Data on Anthracycline-Free Treatment for Early-Stage Triple Negative Breast Cancer. Intensity Therapeutics Inc. published a document regarding a new drug, INT230-6, in clinical testing for breast cancer treatment. The document describes ongoing research on INT230-6, which involves intratumoral injections to locally kill cancer cells and stimulate an immune response. The research focuses on its use in early-stage, operable triple negative breast cancer and explores the potential for anthracycline-free treatment regimens. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intensity Therapeutics Inc. published the original content used to g","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL2wndbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"gpt_icon":0},{"id":"2590988515","title":"Intensity Therapeutics Reports Favorable Early Results from Phase 2 Triple Negative Breast Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2590988515","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590988515?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:47","pubTimestamp":1765457238,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics Inc. has announced the presentation of two posters at the 2025 San Antonio Breast Cancer Symposium . The first poster, PS5-08-16, reports early observations from the INVINCIBLE-4 study, an ongoing randomized Phase 2 clinical trial investigating INT230-6 in combination with standard of care  neoadjuvant immunochemotherapy in patients with early-stage triple negative breast cancer . Preliminary data indicate that the INT230-6 cohort experienced 50% fewer grade 3 or higher adverse events compared to the SOC-alone cohort. Fourteen patients have been treated to date, with safety data for those receiving INT230-6 plus SOC remaining favorable. These results are being presented at the symposium. A second poster, PS4-10-15, outlines a potential Phase 3 clinical study design evaluating INT230-6 plus SOC, with and without the anthracycline doxorubicin, for breast cancer treatment. This presentation also takes place at the SABCS.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL27R3GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2589781231","title":"BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2589781231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589781231?lang=en_us&edition=fundamental","pubTime":"2025-12-06 03:14","pubTimestamp":1764962096,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companiesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL6N3XB0IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FSLY","HUM","TRMB","XOM","HL","OMC","INTS","EXE","COO","ROL","TTAN","BMEA","AMLX","LU0128525929.USD","VSCO","DBRG","CHPT","CDE","LUV","LU0320765646.SGD","LU0128525689.USD","S","ULTA","SCCO","ITT","PSN","AES","PKG","AUB","EUDA","DELL","ZUMZ","HPE","WBD","IOT","FCX","TE","PRAX","LU1150488218.USD","EQT","RBRK","TARA","ALB","FANG"],"gpt_icon":1},{"id":"2589180868","title":"BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Ulta Beauty, Victoria's Secret","url":"https://stock-news.laohu8.com/highlight/detail?id=2589180868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589180868?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:22","pubTimestamp":1764944543,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Ulta Beauty, Victoria's SecretEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning Ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL6N3XB0LA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RBRK","LU2401740654.USD","89888","CHPT","LU1035775433.USD","QCLS","LU1989764664.SGD","LU2477742899.HKD","INTS","PKG","SGXZ23171101.USD","BK4123","TTAN","BK4614","LU0821914370.USD","VSCO","LU1280957306.USD","WBD","LU1863844665.USD","ROL","BK4170","SW","COO","LU1232071149.USD","RGEN","LU0368265764.SGD","LUV","LU0300736062.USD","HPE","S","TRMB","LU0942090050.USD","BMEA","LU1048596156.SGD","PSN","TARA","SWR.UK","ULTA","IE00B0JY6N72.USD","LU0719512351.SGD","ZUMZ","LU2039709279.SGD","IOT"],"gpt_icon":1},{"id":"2589892931","title":"BUZZ-Intensity Therapeutics jumps after Nasdaq grants compliance extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2589892931","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589892931?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:40","pubTimestamp":1764938406,"startTime":"0","endTime":"0","summary":"BUZZ-Intensity Therapeutics jumps after Nasdaq grants compliance extension** Shares of drugmaker Intensity Therapeutics INTS.O rise 8.6% to 50 cents premarket ** Co gets 180-day extension from the Nasdaq exchange to meet the minimum $1 share price requirement** Deadline set for June 1, 2026; shares must stay above $1 for 10 consecutive days, says co** Co continues late-stage trials of INT230-6 for soft tissue sarcoma and breast cancer** INT230-6 is injected into tumors to kill cancer cells and trigger immune response - INTS** Up to last close, stock down ~74% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL4N3XB0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2589189257","title":"BRIEF-Intensity Therapeutics Granted 180-Day Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2589189257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589189257?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:39","pubTimestamp":1764938396,"startTime":"0","endTime":"0","summary":"BRIEF-Intensity Therapeutics Granted 180-Day Extension Dec 5 (Reuters) - Intensity Therapeutics Inc INTS.O:INTENSITY THERAPEUTICS GRANTED 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XA1AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2589892389","title":"Intensity Therapeutics Granted 180-Day Extension to Regain Compliance With Nasdaq's Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2589892389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589892389?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:30","pubTimestamp":1764937817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XA1AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2588870978","title":"BRIEF-Intensity Therapeutics Files For Offering Of Up To $30 Million Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2588870978","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588870978?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:09","pubTimestamp":1764857355,"startTime":"0","endTime":"0","summary":"BRIEF-Intensity Therapeutics Files For Offering Of Up To $30 Million Common Stock - SEC FilingDec 4 (Reuters) - INTENSITY THERAPEUTICS INC - FILES FOR OFFERING OF UP TO $30 MILLION COMMON STOCK - SEC FILINGSource text: [ID:n0001567264-25-000108] ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2588881015","title":"Intensity Therapeutics Unveils New Breast Cancer Therapy Data at 2025 SABCS","url":"https://stock-news.laohu8.com/highlight/detail?id=2588881015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588881015?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:47","pubTimestamp":1764852433,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics Inc. announced two upcoming presentations at the 2025 San Antonio Breast Cancer Symposium, scheduled for December 9-12, 2025. The company will present new clinical research, including a study titled \"Accelerating an Anthracycline-Free Future: A New Drug in Clinical Testing Offers Patients Hope for Safer, More Effective Breast Cancer Therapy Combinations,\" to be presented by Lewis Bender, M.S. M.A. M.B.A., on December 11, 2025. Another presentation, \"Intratumoral Injections of INT230-6 Prior to Neoadjuvant Immuno-chemotherapy in Early-Stage Triple Negative Breast Cancer: Early observations from INVINCIBLE-4-SAKK 66/22 , a Phase II Randomized Clinical Trial,\" will be presented by Andreas Müller, M.D., on December 12, 2025. The results of these studies will be presented at the symposium.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gener","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL21kT80:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2588881024","title":"Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2588881024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588881024?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:47","pubTimestamp":1764852420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUA5P6J6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2588088996","title":"Intensity Therapeutics Inc - Files for Offering of up to $30 Mln Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2588088996","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588088996?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:03","pubTimestamp":1764849783,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INTS","BK4139"],"gpt_icon":0},{"id":"2583305380","title":"Analysts Offer Insights on Healthcare Companies: Curis (CRIS) and Intensity Therapeutics, Inc. (INTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583305380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583305380?lang=en_us&edition=fundamental","pubTime":"2025-11-13 00:00","pubTimestamp":1762963250,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Curis (CRIS – Research Report) and Intensity Therape...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-curis-cris-and-intensity-therapeutics-inc-ints-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-curis-cris-and-intensity-therapeutics-inc-ints-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","BK4581","CRIS","HCSG","INTS","BK4139","XLV","LU0029874061.USD","BK4137","BK4585","BK4588","LABU"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}